REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Boehringer Ingelheim del Ecuador CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Boehringer Ingelheim del Ecuador CIA Ltda Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Boehringer Ingelheim Del Ecuador Cia Ltda forms part of the multinational German group - Boehringer Ingelheim. It is primarily engaged in investigation, development, manufacturing and commercialization of both human and animal grade pharmaceutical products. The group is present 142 countries and counts with more than 47.000 employees globally.

Headquarters
Av. 6 de Diciembre E10-a, Torre 6 Bldg.
Quito; Pichincha;

Contact Details: Purchase the Boehringer Ingelheim del Ecuador CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim del Ecuador CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Boehringer Ingelheim del Ecuador CIA Ltda report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim del Ecuador CIA Ltda report to view the information.
Financial Auditors:
Purchase the Boehringer Ingelheim del Ecuador CIA Ltda report to view the information.
Incorporation Date:
July 30, 1976
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Boehringer Ingelheim del Ecuador CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
9.2%▲
Total operating revenue
9.32%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-15.31%▼
Total assets
9.33%▲
Total equity
-15.26%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.25%▼
Return on Equity (ROE)
0%
Debt to Equity Ratio
15.04%▲
Quick Ratio
-0.02%▼
Cash Ratio
-0.08%▼

Similar companies

Laboratorios Siegfried S.A.
 
Roche Ecuador S.A.
Bayer S.A.
 
Novartis Ecuador S.A.
Laboratorios Industriales Farmaceuticos Ecuatorianos Life
 
Nefrocontrol S.A.
Farmayala Pharmaceutical Company S.A.
 
Indeurec S.A.
Acromax Laboratorio Quimico Farmaceutico S.A.
 
Tecnandina S.A. Tensa
Opella Healthcare Ecuador S.A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo